NCT00235560View on ClinicalTrials.gov

Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

rapamycin

sirolimus

Trial Locations (3)

25000

Service d'Hématologie, Hôpital Jean Minjoz, Besançon

31059

Service d'Hématologie CHU Purpan, Toulouse

49100

Service d'Hématologie, CHU, Angers

All Listed Sponsors
collaborator

French Innovative Leukemia Organisation

OTHER

lead

University Hospital, Toulouse

OTHER

NCT00235560 - Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients | Biotech Hunter | Biotech Hunter